Effect of Erandadighana vati over Kaishora guggulu after Virechan in the management of Vatarakta(Chronic Gout)- A randomised comparative clinical trial - nil

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1.Patients presenting with the clinical features of Vatarakta (sandhi shotha(swelling), sandhi shola(pain), sparsh asahatvam (tenderness), twak vaivarnya(discolouration of skin), raga(redness), vidaha(burning sensation), stabdhata(stiffness))
•2.Patients either sex between age group of 21-60 yrs.
•3.Patients showing the Serum uric acid level 7 -10mg/dl.

•1.Uncontrolled Diabetes and uncontrolled HTN
•2.Subjects pre-diagnosed with autoimmune and infective disease of joints. E.g. tuberculous arthritis
•3.Malignancy
•4.Genetic Disorder e.g. Duchene muscular dystrophy
•5.Pregnant and lactating women
•6.History of hypersensitivity to any of the trial drug ingredient.

发起方